Jean M. Franchi

CIK 1653053 · Chief Financial Officer · last filed 2026-04-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.57M

Companies

5

Total Filings

36

Lifetime Open-Market Net

-$3.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IRON Chief Financial Officer 70,590 $67.99 $4.80M -$1.72M 10 2026-04-15
BDSX Director 108,140 $15.06 $1.63M $0 12 2026-01-06
REPL Chief Financial Officer 128,748 $8.88 $1.14M -$2.01M 9 2023-05-18
MERRIMACK PHARMACEUTICALS INC (MACK) Delisted Chief Financial Officer $15.13 $0 3 2018-12-13
Dimension Therapeutics, Inc. (DMTX) Delisted Chief Financial Officer $0 2 2017-02-03

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-12-11 REPL Grant (A) $0 EDGAR
2018-12-13 MERRIMACK PHARMACEUTICALS INC (MACK) Delisted Grant (A) $0 EDGAR
2018-02-16 MERRIMACK PHARMACEUTICALS INC (MACK) Delisted Grant (A) $0 EDGAR
2017-08-28 MERRIMACK PHARMACEUTICALS INC (MACK) Delisted Grant (A) $0 EDGAR
2017-02-03 Dimension Therapeutics, Inc. (DMTX) Delisted Grant (A) $0 EDGAR
2016-02-02 Dimension Therapeutics, Inc. (DMTX) Delisted Grant (A) $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.